The Journal of Allergy and Clinical Immunology
Volume 119, Issue 6 , Page A41, June 2007

Information for category 1 CME Credit

Article Outline

 

Credit can now be obtained, free for a limited time, by reading the review articles in this issue. Please note the following instructions.

Method of Physician Participation in Learning Process: The core material for these activities can be read in this issue of the Journal or online at the JACI Web site: www.jacionline.org. The accompanying tests may only be submitted online at www.jacionline.org. Fax or other copies will not be accepted.

Date of Original Release: June 2007. Credit may be obtained for these courses until May 31, 2009.

Copyright Statement: Copyright © 2007-2009. All rights reserved.

Overall Purpose/Goal: To provide excellent reviews on key aspects of allergic disease to those who research, treat, or manage allergic disease.

Target Audience: Physicians and researchers within the field of allergic disease.

Accreditation/Provider Statements and Credit Designation: The American Academy of Allergy, Asthma & Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The AAAAI designates these educational activities for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Back to Article Outline

CME article 

“Eosinophilic disorders” 

(page 1291)

List of Design Committee Members: Authors: Dagmar Simon, MD, and Hans-Uwe Simon, MD, PhD

Activity Objectives 


1.To understand the differential diagnosis for eosinophilia.

2.To identify the indications for use of anti–IL-5 antibody.

3.To identify the genetic abnormalities and pathogenesis of eosinophilic leukemia.

Recognition of Commercial Support: This CME activity has not received external commercial support.

Disclosure of Significant Relationships with Relevant Commercial Companies/Organizations: Dagmar Simon and Hans-Uwe Simon have no significant relationships to disclose.

Back to Article Outline

CME article 

“Eosinophil trafficking in allergy and asthma” 

(page 1303)

List of Design Committee Members: Authors: Helene F. Rosenberg, MD, Simon Phipps, PhD, and Paul S. Foster, PhD

Activity Objectives 


1.To list crucial differences between human and mouse eosinophils.

2.To identify the cytokines that affect eosinophil development and trafficking.

3.To become familiar with potential therapeutic targets for eosinophil-associated clinical disorders.

Recognition of Commercial Support: This CME activity has not received external commercial support.

Disclosure of Significant Relationships with Relevant Commercial Companies/Organizations: Simon Phipps has received grant support from the Australian Lung Foundation. Helene F. Rosenberg and Paul S. Foster have no significant relationships to disclose.

PII: S0091-6749(07)00787-7

doi:10.1016/S0091-6749(07)00787-7

The Journal of Allergy and Clinical Immunology
Volume 119, Issue 6 , Page A41, June 2007